• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Innate Pharma SA

+ Add to Watchlist

IPH:FP

8.0000 EUR 0.0800 1.01%

As of 08:00:00 ET on 12/24/2014.

Snapshot for Innate Pharma SA (IPH)

Open: 7.9700 Day's Range: 7.8200 - 8.1100 Volume: 150,688
Previous Close: 7.9200 52wk Range: 4.8700 - 12.3000 1-Yr Rtn: +62.93%

Stock Chart for IPH

No chart data available.
  • IPH:FP 8.0000
  • 1D
  • 1M
  • 1Y
7.9200
Interactive IPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IPH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -0.2000
Est. EPS (EUR) (12/2014) -0.3130
Est. PEG Ratio -
Market Cap (M EUR) 423.72
Shares Outstanding (M) 52.97
30 Day Average Volume 452,165
Price/Book (mrq) 4.3083
Price/Sale (ttm) 35.2861
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IPH

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for IPH

Innate Pharma S.A. is a biopharmaceutical company. The Company develops first in class drugs that focus on cancer immunotherapy through the manipulation of the innate immune system.

Herve BraillyChairman-Mgmt Board/CEOPierre F DodionChief Medical Officer
Catherine MoukheibirExec VP/Senior Advisor:FinanceJerome TiollierExec VP/Chief Dev Officer
More Company Profile & Key Executives for IPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil